Sponsored Links

Elixir Pharmaceuticals withdraws IPO plans

WASHINGTON | Fri May 9, 2008 5:14pm EDT

WASHINGTON May 9 (Reuters) - Elixir Pharmaceuticals Inc on Friday filed with regulators to withdraw its plans for an initial public offering due to "market conditions."

The company had previously filed to sell 5 million shares at an estimated price range of $14 to $16 each. (Reporting by Karey Wutkowski; editing by Carol Bishopric)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.